Browse Articles

Discover research articles across all indexed journals

Development of a blended MOOC implementation model for English language learning: An interpretive structural modeling approach

PLoS ONE Anh Tuan Pham, Muhammad Ridhuan Tony Lim Abdullah Jul 01, 2026 DOI: 10.1371/journal.pone.0338980

The integration of Massive Open Online Courses (MOOCs) into traditional English language education has created new opportunities for scalable, flexible, and inclusive learning. However, existing studies on MOOCs and blended learning remain largely descriptive and lack a structured framework that prioritizes key implementation elements for effective integration into formal education. This study develops a structured implementation model for blended MOOCs (bMOOCs) tailored to undergraduate English as a Foreign Language (EFL) instruction. This gap is particularly evident in specific contexts such as Vietnam, where institutional conditions, technological readiness, and learner characteristics significantly influence implementation effectiveness. Using the Interpretive Structural Modelling (ISM), the research identifies and validates 20 key sub-indicators grouped into three interconnected phases: planning, implementation, and evaluation. The model emphasizes the importance of analyzing learners’ backgrounds and motivations, setting clear learning objectives, and selecting appropriate materials and technologies. During implementation, the focus shifts to effective instructional strategies, learner participation, and technical support. The evaluation phase prioritizes formative assessment and timely feedback to promote continuous improvement and engagement. This learner-centered approach addresses common challenges in blended learning environments. The model offers practical guidance for stakeholders in EFL education, such as administrators, educators, and curriculum developers, seeking to enhance English language education through blended MOOCs. Practical implications for the implementation of blended MOOCs in EFL instruction are also addressed to enhance the quality of English language instruction in the digital age.

Nationwide survey reveals gender disparities in cardiovascular awareness and lifestyle behaviors among polish adolescents aged 18 years

Scientific Reports Piotr Dobrowolski, Agnieszka Doryńska, Witold Śmigielski et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60296-1

Amide Monomer‐Mediated Solubilization Strategy Enables Nonflammable Deep Eutectic Gel Polymer Electrolytes for High‐Temperature‐Stable Lithium Metal Batteries

Advanced Materials Huaifang Shang, Xiaoye E, Guoqiang He et al. Jul 01, 2026 DOI: 10.1002/adma.73748

ABSTRACT Deep eutectic gel polymer electrolytes (DEGPEs), combining intrinsic non‐flammability with outstanding thermal stability, are attractive candidates for next‐generation lithium metal batteries (LMBs). However, their practical deployment in high‐energy‐density LMBs has been fundamentally constrained by poor interfacial stability with the lithium metal anode and limited tolerance toward the high‐voltage cathode. We report a new amide‐monomer‐mediated DEGPE that achieves comprehensive performance via a LiNO 3 solubilization strategy. The N‐methylacrylamide (NME) units in the poly(N‐methylacrylamide) (PNME) framework enhance LiNO 3 solubility through hydrogen bonding and Li + coordination, forming a stable inorganic‐rich interphase. Concurrently, it immobilizes free N‐methyltrifluoroacetamide (NMTFA) via hydrogen bonds, suppressing transition‐metal dissolution and preventing electrolyte leakage. The amide monomer‐mediated DEGPE‐based NCM811||Li cells achieve 80.1% capacity retention after 500 cycles with an average Coulombic efficiency of 99.67%, a performance that surpasses state‐of‐the‐art (deep eutectic electrolyte) DEE‐based systems. More impressively, LCO||Li cells retain 89.6% capacity after 300 cycles even at an elevated temperature of 80°C, far exceeding the thermal stability limits of conventional electrolytes and underscoring its remarkable interfacial stability under extreme operational conditions. This work establishes a molecularly engineered solvation and interfacial regulation strategy for DEGPEs, providing both fundamental insight and a practical pathway toward safe, high‐energy, and high‐temperature‐tolerant LMBs.

Constitutive activation of a hybrid two-component regulator reveals cross-regulation of polysaccharide utilization genes in Bacteroides

Journal of Biological Chemistry Rong Gao, Brynn Sillick, Leonard M. Thomas et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113195

From the outback to oncology suites : Redefining cancer care for rural and Aborginal Australians.

Journal of Clinical Oncology Mathew George, Jennifer Hamilton, Vinod Mathai Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.331

331 Background: For too long, an Aboriginal Australian's postcode has predicted their cancer outcome. In north-western New South Wales, vast distances, late diagnosis, and systemic disadvantage have created a cancer equity crisis. In 2011, we established the Moree Aboriginal Medical Oncology Outreach Clinic, a sustained hub and spoke model bringing specialist oncology directly into Aboriginal communities. This is not a pilot. It is a 15-year proof that equity is achievable. Methods: A prospective hub and spoke framework linked the Tamworth oncology hub to outreach clinics in Moree (2011) and Narrabri (2022). A multidisciplinary team including a medical oncologist, clinical nurse consultant, chemotherapy nurses, and social worker collaborated with Aboriginal health workers and local GPs. Telehealth was integrated across consultations, treatment monitoring, shared care follow-up, and tele-trials, enabling Aboriginal and rural patients to access clinical research without leaving their community. Service activity from January 2011 to October 2023 was analyzed descriptively. Results: Fifteen years of sustained outreach delivered measurable impact. In total, 1,851 unique patients were cared for including 362 Indigenous patients across 9,194 clinical occasions of service. A total of 10,422 chemotherapy and immunotherapy appointments were delivered locally. A total of 1,067 patients accessed 4,261 telehealth consultations with 76% satisfaction. Tele-trials dismantled the historic exclusion of Indigenous Australians from cancer research. Expansion to Narrabri in 2022 confirmed scalability. AUD 380,000 in Cancer Institute of NSW grants funded Aboriginal community engagement programs. When you bring care to the community, the community comes to care. Conclusions: The Moree Narrabri Oncology Outreach Model proves the tyranny of distance can be overcome. Integrating specialist outreach, telehealth, tele-trials, and Aboriginal community partnership into one scalable framework, this 15-year service is not just a model for Australia. It is a roadmap for every underserved community across the Asia-Pacific and beyond. Where you live should never determine whether you live.

Camrelizumab plus rivoceranib as first-line maintenance therapy after camrelizumab-chemo induction in advanced esophageal squamous cell carcinoma: A prospective, single-arm, phase II clinical trial.

Journal of Clinical Oncology Na Song, Jinglei Qu, Ying Chen et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.tps158

TPS158 Background: ESCORT-1st, a global phase III trial evaluating camrelizumab (Cam) plus paclitaxel and cisplatin (TP) as first-line therapy for advanced esophageal squamous cell carcinoma (ESCC), showed a significant improvement in median overall survival (OS) compared with placebo plus TP (15.6 vs 12.6 months; HR 0.70; p < 0.0001). However, the overall efficacy of first-line ICIs plus chemotherapy in ESCC remains limited, with frequent resistance and disease progression occurring within 5–7 months, highlighting the need to further optimize current treatment strategies. The combination of ICIs and tyrosine kinase inhibitors (TKIs) has shown potential synergistic antitumor activity. TQB2450-II-13, a phase II clinical study, showed that bemossumab combined with anlotinib plus paclitaxel and cisplatin as first-line therapy for unresectable locally advanced, recurrent, or metastatic ESCC achieved a median progression-free survival (PFS) of 14.9 months (95% CI, 11.4–NE), an objective response rate (ORR) of 72.0%, a DCR of 84.0%, and a median duration of response (DoR) of 16.2 months (95% CI, 10.2–NE), indicating encouraging clinical activity. Therefore, this study aims to evaluate the efficacy and safety of camrelizumab plus rivoceranib (Cam+Rivo) as maintenance therapy following first-line Cam+TP induction in patients with advanced ESCC. Methods: This is a prospective, exploratory clinical study. Key eligibility criteria included age 18–75 years, stage IV ESCC, ECOG 0–1, achieved CR/PR/SD after 4–6 cycles of first-line induction with Cam+TP, and adequate organ function. Prior treatment–related toxicities were required to have resolved to ≤ grade 1 or baseline. Eligible patients initiated maintenance therapy within 6 weeks after completion of the last cycle of first-line induction, consisting of Cam (200 mg, IV, day 1) plus Rivo (250 mg, PO, qd), administered every 3 weeks (Q3W) until disease progression or unacceptable toxicity. The primary endpoint was PFS, defined as the time from initiation of maintenance therapy to the first documented disease progression. Secondary endpoints included ORR, DoR, OS, and safety. Exploratory endpoints included immune cell infiltration, inflammatory cytokine profiles, and lymphocyte subset analyses. Clinical trial information: ChiCTR2600116141 .

Fossil fuel emissions dominate Northern Hemisphere CO2 seasonal cycle trends under mitigation scenarios

Nature Communications Zhe Jin, Yue He, Yilong Wang et al. Jul 01, 2026 DOI: 10.1038/s41467-026-75003-x

Abstract Variations in the atmospheric CO 2 seasonal cycle across the Northern Hemisphere have historically been dominated by terrestrial ecosystems, making ground-based observations a reliable proxy for terrestrial carbon dynamics. However, whether this dominance will persist in the future remains uncertain. Here we combine atmospheric transport modeling with factorial simulations to assess and attribute future changes in the CO 2 seasonal cycle through 2100. We show that the dominant drivers of these changes shift fundamentally across scenarios. Under the high-emission scenario (SSP5-8.5), strengthening land sinks dominate and amplify CO 2 seasonal variability, preserving ground-based observations as a reliable terrestrial proxy. In contrast, under the low-emission scenario (SSP1-2.6), CO 2 seasonal amplitude declines widely, driven primarily by reduced fossil fuel emissions and their dampened seasonality. Consequently, established ground-based CO 2 observations may no longer reliably track terrestrial carbon dynamics under mitigation pathways, underscoring the need for new approaches for monitoring and climate policy verification.

Synthesis and Structures of Formal Ni(I/II/III) Imido Complexes

Journal of the American Chemical Society Baolu Wang, Qiyi Miao, Shiying Zhang et al. Jul 01, 2026 DOI: 10.1021/jacs.6c00156

A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer

PLoS ONE Sandani De Vass Gunawardane, Matheen Muhammadh Milhan, Poorni Chanuka Rathnayake et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352420

Vernolac is a commercially available polyherbal nutraceutical capsule containing Vernonia zeylanica aerial parts, Nigella sativa seeds, Hemidesmus indicus roots, Leucas zeylanica aerial parts, and Smilax glabra rhizome. Herbal formulations, organic extracts, and isolated phytochemicals from these plants have demonstrated anticancer properties. However, the mechanisms underlying Vernolac’s anticancer activity as a polyherbal formulation remain largely unexplored. This study utilized an integrative network pharmacology-based approach, supported by in vitro experiments, to investigate Vernolac’s anticancer potential. Phytochemicals were retrieved from databases, screened for drug-likeness and oral bioavailability using SwissADME, yielding 155 drug-like compounds, and their protein targets were predicted using SwissTargetPrediction. The intersection of phytochemical targets with cancer-related targets from GeneCards identified 137 common targets. Protein-protein interaction analysis using STRING and Cytoscape revealed fourteen key hub nodes, including AKT1, BCL2, CASP3, CTNNB1, EGFR, ESR1, GAPDH, HSP90AA1, HSP90AB1, IL6, JUN, SRC, STAT3, and TNF. Network analyses highlighted key phytochemicals, including vernolactone, thymoquinone, quercetin, nigellidine, α-hederin, and carvacrol. GC–MS profiling of the supercritical CO 2 extract of Vernolac revealed a diverse phytochemical composition enriched with terpenes, fatty acids, and sterols, including the key constituents stigmasterol, thymoquinone, and carvacrol. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses revealed significant enrichment of the identified targets across multiple cancer pathways. Molecular docking and dynamics simulations identified novel target-ligand interactions, such as vernolactone-β-catenin and α-hederin-CDK4. The Sulforhodamine B assay demonstrated selective antiproliferative activity of Vernolac extract against cancerous cell lines MCF-7 (IC 50  = 54.01 ± 0.02 μg/mL), Caco-2 (IC 50  = 85.52 ± 0.13 μg/mL), NTERA-2 cl.D1 (IC 50  = 42.41 ± 0.06 μg/mL), and non-cancerous MCF-10A (IC 50  = 803.5 ± 0.03 μg/mL). Collectively, network analysis suggests that phytochemicals in Vernolac may exert anticancer effects through multiple cancer-related pathways, including those associated with apoptosis, immune modulation, oxidative stress, inflammation, and cell proliferation. Furthermore, the identified targets and enriched pathways suggest a potential role in modulating drug resistance and treatment response, providing a computational basis for its application as an adjunct to conventional cancer therapies and warranting further investigation in preclinical and clinical settings.

Consensus-based radiographic threshold for identifying vertical periodontal bone loss: an international observer study

Scientific Reports Omar A. Al-Karadsheh, Siraj Zabadi, Mohammad H. Hatamleh et al. Jul 01, 2026 DOI: 10.1038/s41598-026-59568-7

The landscape for therapeutic cancer vaccines

Nature Reviews Drug Discovery Congzhou Chen, Xue Wang, Wei Wei et al. Jul 01, 2026 DOI: 10.1038/d41573-026-00063-z

Restoring cortical disinhibition improves Huntington’s disease phenotypes

Nature Sonja Blumenstock, David Arakelyan, Nicholas del Grosso et al. Jul 01, 2026 DOI: 10.1038/s41586-026-10671-9

Abstract Huntington’s disease (HD) is a devastating movement disorder without a cure at present 1 . Although the monogenic basis of HD is well defined 2 , the complex downstream effects that underlie behavioural symptoms are poorly understood. These effects include cortical dysfunction 3,4 , yet the roles of specific cortical neuronal subtypes in HD symptoms remain largely unexplored. Here we used longitudinal in vivo two-photon calcium imaging to examine the activity of three cortical inhibitory neuron (IN) subtypes and excitatory corticostriatal (CStr) projection neurons in the motor cortex of the transgenic R6/2 HD mouse model throughout disease progression. We found that motor deficits in R6/2 mice were accompanied by neuron subtype-specific abnormalities in movement-related activity. This included marked hypoactivity of vasoactive intestinal peptide (VIP)-INs and CStr neurons, which was also observed in the knock-in zQ175DN HD mouse model. Optogenetic activation of VIP-INs in R6/2 mice restored healthy levels of activity in VIP-INs and their downstream CStr neurons and ameliorated motor deficits in R6/2 mice; behavioural improvements persisted for days after stimulation. Our findings highlight cortical INs as a potential therapeutic target for HD.

Interlayer Valley Coupling and Hybridized Excitons in Twisted van der Waals Bilayers With Broken Translational Symmetry

Advanced Materials Xing Xie, Junying Chen, Shaofei Li et al. Jul 01, 2026 DOI: 10.1002/adma.73772

ABSTRACT Twisted van der Waals (vdW) bilayers allow the moiré potential and interlayer coupling to be tuned through the relative rotation between layers, providing a platform to study moiré physics. At large twist angles, the lack of translational symmetry allows intralayer and interlayer valley momenta to be connected by Umklapp processes, in principle permitting unconventional intervalley coupling. However, direct experimental evidence of such couplings in twisted vdW bilayers with broken translational symmetry has been limited. Here, we observe interlayer coupling between the K and −K valleys in twisted MoS 2 bilayers by detecting intense photoluminescence from high‐energy interlayer hybridized excitons. These hybridized excitons are absent in commensurate twisted MoS 2 homobilayers and display an almost vanishing valley Zeeman splitting, indicative of strong mixing between intralayer and interlayer excitonic states. This hybridization gives rise to an unusual magnetic‐field‐dependent valley polarization in excitons with distinct spin configurations. With increasing temperature, the hybridized excitons detune, and their energies approach those of intralayer excitons, revealing a sensitive interplay between moiré coupling and thermal effects. Our results uncover a key role of broken translational symmetry in excitons of twisted MoS 2 bilayers and open a route to exploring quantum phenomena in aperiodic twisted MoS 2 materials.

Cyclic GMP-dependent activation of Ca2+ release from the ER and digestive vacuole at distinct phases of intraerythrocytic Plasmodium falciparum development

Journal of Biological Chemistry Maneesh K. Singh, Rute I. Honorio, Paula J. Bartlett et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113346

Efficacy and safety of intrathecal pemetrexed in the treatment of leptomeningeal metastases from ALK-mutant NSCLC: A prospective, multi-center, single-arm, phase II clinical trial.

Journal of Clinical Oncology Xiaowei Song, Chong Teng, Siqi Man et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.265

265 Background: This study aimed to evaluate the efficacy and safety of intrathecal pemetrexed (IP) in the treatment of leptomeningeal metastases (LM) from ALK-mutant non-small-cell lung cancer (NSCLC). Methods: This prospective, multi-center, single-arm, phase II clinical trial enrolled 25 patients with ALK-mutant NSCLC and LM who had failed multi-line treatments. Patients had failed multi-line treatments received IP twice during the first week (Day 1 and Day 5), followed by once every 3-4 weeks until disease progression (PD), intolerance, or refusal of further treatment. The primary endpoint was overall survival (OS), and secondary endpoints included objective response rate (ORR) and adverse events (AEs). LM response was assessed using the Response Assessment in Neuro-Oncology (RANO) criteria. Results: The median overall survival (mOS) was 18.0 months (95% confidence interval [CI]: 13.0–23.6 months), with the RANO-assessed response rate of 76% (19/25). The most common adverse event was myelosuppression (n = 13; 52%), which was reversible with symptomatic treatment. Conclusions: This study demonstrates that IP is a safe and effective treatment for ALK-mutant NSCLC-LM, with a median OS exceeding 18 months. To our knowledge, this is the first prospective study to evaluate IP in this patient population, highlighting its potential as a promising therapeutic option for LM. Clinical trial information: ChiCTR1800016615 .

Germline testing in pancreatic adenocarcinoma: A retrospective cohort study of germline genetic testing uptake, patterns of referral, clinical findings and impact in the South Western Sydney Local Health District.

Journal of Clinical Oncology Huei Ti Soh, Stephanie Hui-Su Lim, Emilia Ip et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.115

115 Background: Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival <12%. Universal germline genetic testing is recommended as pathogenic variants are identified in 8–15% of patients and guide therapy: BRCA1/2 and PALB2 predict platinum and PARP inhibitor sensitivity, while mismatch repair deficiency predicts immunotherapy response. Mutation detection rates in culturally and linguistically diverse (CALD) populations are not well described and may be influenced by inequitable access to genetic services. We evaluated germline testing patterns in PDAC patients within the culturally diverse South Western Sydney Local Health District (SWSLHD). Methods: Retrospective cohort study of PDAC diagnosed in SWSLHD (Jan 2020–Jun 2025). Data were extracted from electronic medical records and oncology databases. Variables included demographics, CALD status, tumour stage, referral pathway (mainstreaming vs genetics clinic), germline testing uptake and results, tumour molecular testing, treatment, and survival. Primary outcomes were germline referral and testing rates. Results: 60/300 diagnosed patients were analysed to date (data collection ongoing). 15/60 (25%) were referred for germline testing; 13/15 completed testing and 2/15 did not proceed (1 unclear, 1 deceased). Of those referred, 9/15 were Australian-born and 6/15 overseas-born; interpreter use was documented in 1 case. Family history of cancer was present in 8/15, absent in 3/15, and undocumented in 4/15. No patients underwent somatic next-generation sequencing and MMR testing was not routinely performed. No pathogenic variants were detected. 2/13 (15%) had variants of uncertain significance; both received genetic counselling and management did not change. Conclusions: Preliminary data demonstrate low germline testing rates (25%) within a highly diverse Australian population. The observed VUS rate (15%) is consistent with published literature (approximately 15–25%). Despite universal testing recommendations, implementation gaps remain. Ongoing data collection will determine whether overall pathogenic variant detection approaches expected rates (8–15%) and will inform strategies to improve equitable access to precision oncology in PDAC.

Tectonically driven integration of the 4.8 Ma Colorado River USA tracked with detrital sanidine and fish genetics

Nature Communications K. E. Karlstrom, M. T. Heizler, A. Aslan et al. Jul 01, 2026 DOI: 10.1038/s41467-026-75006-8

Fast Interfacial Hole Consumption Suppresses Space–Charge Layer Trap Filling in BiVO <sub>4</sub> Photoanodes

Journal of the American Chemical Society Longren Li, Tong Wang, Beier Hu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c05776

Determining optimal practices for foal weaning – A protocol for a systematic review and network meta-analysis

PLoS ONE Nicole Cranston, Petra Buckley, Lorraine Rose et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352182

Background Weaning is a stressful time in a foal’s ( Equus caballus ) life. As humans artificially manage weaning in domestic horses, it provides an opportunity to safeguard horse welfare early in life, with potential long-term benefits. While numerous studies have examined the effects of different weaning and management interventions on foal stress, optimal weaning practices have yet to be identified. Overall purpose of the study: To identify which weaning interventions and management practices have the greatest potential to improve foal welfare based on physiological and behavioural outcomes. Research questions: (1) What physiological and behavioural changes occur in foals in response to artificial weaning? (2) Do different interventions during weaning produce different physiological and behavioural outcomes in foals? (3) How do study-level characteristics explain heterogeneity in foal outcomes during weaning, and which impact welfare outcomes across different interventions? (4) Which interventions, management practices, or combinations thereof most effectively optimise foal welfare during weaning? Methodology Six databases were searched on 24 August 2025. Database search strings were based on the Population-Intervention-Comparator-Outcome (PICO) framework and were PRESS-reviewed. Additional studies, including grey literature, will be identified through dissertation databases, ScienceDirect, Google Scholar, and by hand-searching the reference lists of included studies and narrative reviews, to ensure a comprehensive search. Articles will be selected based on predefined eligibility criteria. Two reviewers will independently conduct title/abstract and full-text screening, data extraction, and assess risk of bias and confidence in the evidence (GRADE and CINeMA). Results will be synthesised through pairwise and Bayesian network meta-analysis using R Statistical Software. Conclusion This systematic review will be the first to investigate foal welfare during artificial weaning, and the findings are expected to provide evidence-based recommendations to improve foal welfare. This paper outlines the protocol that will be used and does not contain any empirical results. Registration This systematic review protocol was registered on the Open Science Framework (OSF) on 19 May 2025 ( https://doi.org/10.17605/OSF.IO/DJWQY ).

When and how to partition airspace: a data-driven control framework for dynamic airspace sectorization based on multi-objective receding horizon optimization

Scientific Reports Jinghan Du, Hongwei Li, Weining Zhang Jul 01, 2026 DOI: 10.1038/s41598-026-57549-4